Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5173 USD | -0.50% |
|
-2.05% | -83.84% |
22/05 | Maxim Downgrades Virpax Pharmaceuticals to Hold From Buy | MT |
15/05 | Virpax Prices Public Offering of Shares, Warrants; Shares Tumble | MT |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Gudin
FOU | Founder | 58 | 01/17/01 |
Gerald Bruce
CEO | Chief Executive Officer | 68 | 01/17/01 |
Vinay Shah
DFI | Director of Finance/CFO | 62 | 20/23/20 |
Sheila Mathias
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Bruce
CEO | Chief Executive Officer | 68 | 01/17/01 |
Jeffrey Gudin
FOU | Founder | 58 | 01/17/01 |
Barbara Ruskin
BRD | Director/Board Member | - | 24/23/24 |
Eric Floyd
CHM | Chairman | 62 | 01/17/01 |
Jerrold Sendrow
BRD | Director/Board Member | 79 | 01/17/01 |
Vanila Singh
BRD | Director/Board Member | 53 | 01/20/01 |
Director/Board Member | 60 | 01/17/01 | |
Michael Dubin
BRD | Director/Board Member | 68 | 26/21/26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,741,600 | 2,440,340 ( 89.01 %) | 0 | 89.01 % |
Company contact information
![address Virpax Pharmaceuticals, Inc.(VRPX)](https://cdn.zonebourse.com/static/address/119073351.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.84% | 14.25L | |
+38.65% | 3.91TCr | |
-8.62% | 3.88TCr | |
+26.95% | 3.12TCr | |
+10.74% | 2.59TCr | |
-13.50% | 2.58TCr | |
+44.87% | 1.41TCr | |
+34.36% | 1.31TCr | |
-7.14% | 1.13TCr | |
-12.61% | 1.07TCr |
- Stock Market
- Equities
- VRPX Stock
- Company Virpax Pharmaceuticals, Inc.